Cannabis Stocks Continue Skyrocketing Amid Florida And Global Legalization Advances
Discover how legalization in Florida and Germany fuels a significant surge in cannabis stocks like Aurora, Canopy Growth, and TILT Holdings.
Jim Belushi’s Premium Cannabis Hits Maryland Via Partnership With State’s Largest Weed Producer
SunMed Growers and Belushi's Farm team up to launch premium, sustainable cannabis in Maryland. Discover the exclusive events on April 3-4.
534% Revenue Surge Unveiled By Israeli CBD-Focused Pharma Company, Exceeding Expectations
Innocan Pharma's 2023 earnings report: Revenue soars 534%, operating loss down 61%, $1.5M capital raise. CEO shares strategic vision.
Celebrating 4/20 With Purpose: Wana Brands Surpasses $4.2M In Charitable Donations Since 2021
Discover how Wana Brands transforms 4/20 with over $4.2M donated to charities, championing community, sustainability, and global betterment.
This Israeli Cannabis Operator Anticipates $95.4M In Revenue Despite Gaza Conflict
Discover how InterCure thrives in 2023 with $95.4M revenue, despite challenges, and plans for global expansion into the U.S. and Germany.
Canadian Cannabis Giant Sets Stage For Growth With $18.5M Public Offering
Discover OrganiGram's strategic $25M public offering aimed at fueling growth and shaping the future of the cannabis industry.
Cannabis Finance Company Silver Spike Announces Solid 2023 Gains
Discover Silver Spike Investment Corp.'s robust 2023 financial performance, strategic acquisitions, and dividend news.
Lowell Farms Navigates Challenging Terrain With 35% Revenue Dip: A Look At 2023’s Financial Outcomes
Discover Lowell Farms Inc.'s Q4 2023 financial report: revenue dips, strategic shifts, and CEO insights shaping the cannabis landscape.
IGC Pharma Announces Q3 2024 Earnings: Strategic Patent Achievements Propel Forward Amid Losses
IGC Pharma's Q3 2024 results: Navigating financial dips with strategic patents in pain treatment and Alzheimer's therapy.
Aurora Cannabis (ACB): Canaccord Genuity Analysts Say Now’s The Time To Buy. Find Out Why
Aurora Cannabis gets upgraded to 'Buy' by Canaccord Genuity analysts, spotlighting strategic growth and the MedReleaf Australia acquisition."